Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06402331 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Fusion Pharmaceuticals Inc. |
| Last Updated on CT.gov | October 9, 2025 (Oct 9, 2025) |
As of March 2, 2026: Clinical trial NCT06402331 is currently recruiting participants. This clinical trial study for prostate cancer is actively seeking new participants at 18 locations across the United States. The study is sponsored by Fusion Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06402331 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06402331 was last updated Oct 9, 2025 (October 9, 2025). HelloStudys verifies this status automatically.